drugset / Trial / NCT04322357

Twice Weekly Steroids and Exercise as Therapy for DMD

NCT04322357 ↗

RandomizedParallel-groupOpen-labelSupportive care

Summary

The study team will determine the potential of low dose twice weekly prednisone and whether exercise training can synergize to delay disease progression and improve muscle strength/physical function in boys with Duchenne muscular dystrophy (DMD). Current standard of care (daily prednisone) is associated with adverse side effects. Evidence from DMD mouse models suggest that weekly dosing provides same efficacy without side effects. Appropriate exercise may also benefit but this area has not been adequately explored.

Timeline

Start
2020-07-30
Primary completion
2024-12-04
Completion
2025-09-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 0.75 mg/kg —